Editor’s Choice – Volume 15 N° 3

Kamil Ugurbil et al provide an in-depth view of the various applications of high field imaging, using animal models.

Rebecca Birnbaum and Daniel Weinberger look at imaging genetics in schizophrenia research, with a discussion of effective connectivity modeling and polygenic risk.

Shitij Kapur et al describe findings derived from molecular imaging techniques in schizophrenia, mood disorders, Parkinson’s disease, and dementia.

Current Issue

March 2014 - Vol 16 - No. 1

New Therapeutic Targets and the Pathobiology of Depression


Editorial | Download

In This issue

Pierre Schulz, David Rubinow

In This Issue | Download

Redesigning antidepressant drug discovery

Florian Holsboer (Germany)

Full Text | Download PDF

Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections

Ronald S. Duman (USA)

Full Text | Download PDF

Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders

Alexandre Dayer (Switzerland)

Full Text | Download PDF

Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications

Yogesh Dwivedi (USA)

Full Text | Download PDF

Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder

Daniel Martins-de-Souza (Brazil)

Full Text | Download PDF

Functional neuroimaging studies of the effects of psychotherapy

Mario Beauregard (USA)

Full Text | Download PDF

Deep brain stimulation in the treatment of depression

Sibylle Delaloye; Paul E. Holtzheimer (USA)

Full Text | Download PDF

Endogenous and exogenous electric fields as modifiers of brain activity: rational design of noninvasive brain stimulation with transcranial alternating current stimulation

Flavio Fröhlich (USA)

Full Text | Download PDF

Neurofeedback and networks of depression

David E. J. Linden (UK)

Full Text | Download PDF

Henri Laborit and the inhibition of action

Edward Kunz, MD

Full Text | Download PDF